Xiolife Pharmaceuticals And Healthcare Private Limited
Pharmaceutical company manufacturing and researching drugs, with registered office in Assam.
2018 | Kamrup, Assam (India) | Active
Xiolife Pharmaceuticals And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 2.60 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -41.31%
- Profit Growth -43.96%
- Ebitda -981.72%
- Net Worth -31.82%
- Total Assets -17.92%
About Xiolife Pharmaceuticals And Healthcare
Xiolife Pharmaceuticals And Healthcare Private Limited (XPAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 2018 (Six years and nine months 5 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.60 M, as per Ministry of Corporate Affairs (MCA) records.
Arup Nath and Sandhyamika Devi serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85320AS2018PTC018673
- Company No.
018673
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2018
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Pharma
Healthcare
Xiolife Pharmaceuticals And Healthcare Private Limited
Explore comprehensive data for Xiolife Pharmaceuticals And Healthcare Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Xiolife Pharmaceuticals And Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arup Nath  | Director | 21-Aug-2018 | Current |
| Sandhyamika Devi | Director | 21-Aug-2018 | Current |
Financial Performance of Xiolife Pharmaceuticals And Healthcare.
Xiolife Pharmaceuticals And Healthcare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.31% decrease. The company also saw a substantial fall in profitability, with a 43.96% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xiolife Pharmaceuticals And Healthcare?
In 2023, Xiolife Pharmaceuticals And Healthcare had a public holding of 28.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Mednomic Healthcare Private Limited
Arup Nath and Sandhyamika Devi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xiolife Pharmaceuticals And Healthcare?
Unlock and access historical data on people associated with Xiolife Pharmaceuticals And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xiolife Pharmaceuticals And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xiolife Pharmaceuticals And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Xiolife Pharmaceuticals And Healthcare
Recent activity within the organization
- Annual General Meeting
Xiolife Pharmaceuticals And Healthcare Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
- Balance Sheet
Xiolife Pharmaceuticals And Healthcare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Shillong.
- Director Appointment
Arup Kumar Nath was appointed as a Director was appointed as a Director on 21 Aug 2018 & has been associated with this company since 6 years 9 months .
- Director Appointment
Sandhyamika Devi was appointed as a Director was appointed as a Director on 21 Aug 2018 & has been associated with this company since 6 years 9 months .
- Company Incorporation
Xiolife Pharmaceuticals And Healthcare Private Limited was registered on 21 Aug 2018 with Roc Shillong & aged 6 years 9 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Xiolife Pharmaceuticals And Healthcare Private Limited?
Xiolife Pharmaceuticals And Healthcare Private Limited was incorporated on 21 Aug 2018.
What is authorized share capital and paid-up capital of Xiolife Pharmaceuticals And Healthcare Private Limited?
The authorized share capital of Xiolife Pharmaceuticals And Healthcare Private Limited is ₹ 5.00 M and paid-up capital is ₹ 2.60 M.
Who are the current board members & directors of Xiolife Pharmaceuticals And Healthcare Private Limited?
Currently 2 directors are associated with Xiolife Pharmaceuticals And Healthcare Private Limited.
- Arup Kumar Nath
- Sandhyamika Devi
What is the registered address of Xiolife Pharmaceuticals And Healthcare Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Xiolife Pharmaceuticals And Healthcare Private Limited is C/O Sarba Nanda Nath H/No. 8 Rupnagar, Ulubari India, Guwahati, Assam, 781005.
What is the corporate identification number (CIN) and company number of Xiolife Pharmaceuticals And Healthcare Private Limited?
The corporate identification number (CIN) of Xiolife Pharmaceuticals And Healthcare Private Limited is U85320AS2018PTC018673 and the company number is 018673 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Xiolife Pharmaceuticals And Healthcare Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Xiolife Pharmaceuticals And Healthcare Private Limited has fallen by -41.31%.
What change has been observed in the net worth of Xiolife Pharmaceuticals And Healthcare Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Xiolife Pharmaceuticals And Healthcare Private Limited has experienced an downturn of -31.82%.
When was the last Balance Sheet of Xiolife Pharmaceuticals And Healthcare Private Limited filed with the ROC?
The most recent Balance Sheet for Xiolife Pharmaceuticals And Healthcare Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records